Herbert Pang

Herbert Pang is an Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics at Duke University, specializing in statistical methodologies for clinical trials, genomics, and pathway analysis. His work spans hybrid control integration, predictive modeling, and real-world evidence applications in oncology and public health.

Education:

• Ph.D. in Biostatistics, Yale University (2008)

Research Focus:
Herbert’s research centers on biomarker clinical trial design, longitudinal data analysis, and machine learning applications in oncology. Key areas include hybrid trial methodologies, dietary trend analysis, and surrogacy assessment for survival outcomes.

Publication Trends (2025–2023):
Recent publications emphasize causal inference frameworks, AI/ML in clinical development, and hybrid control trials. Topics span dietary macrotrends (sodium/fiber consumption), oncology predictive models, and statistical innovation in pharmaceutical research.

Grants:

• National Institutes of Health (2006–2012): Anti-VEGF efficacy vs. toxicity in tumors/wounds
• National Institutes of Health (2009–2012): Alcohol’s effects on liver injury repair